These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 19141713

  • 1. Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
    Hadlock GC, Baucum AJ, King JL, Horner KA, Cook GA, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2009 Apr; 329(1):169-74. PubMed ID: 19141713
    [Abstract] [Full Text] [Related]

  • 2. Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation.
    Hadlock GC, Chu PW, Walters ET, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2010 Oct; 335(1):207-12. PubMed ID: 20622144
    [Abstract] [Full Text] [Related]

  • 3. Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.
    Chauhan H, Killinger BA, Miller CV, Moszczynska A.
    Int J Mol Sci; 2014 Apr 08; 15(4):5884-906. PubMed ID: 24717411
    [Abstract] [Full Text] [Related]

  • 4. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism.
    Baucum AJ, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE.
    J Neurosci; 2004 Mar 31; 24(13):3436-43. PubMed ID: 15056723
    [Abstract] [Full Text] [Related]

  • 5. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
    Metzger RR, Haughey HM, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2000 Dec 31; 295(3):1077-85. PubMed ID: 11082443
    [Abstract] [Full Text] [Related]

  • 6. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
    Sandoval V, Riddle EL, Ugarte YV, Hanson GR, Fleckenstein AE.
    J Neurosci; 2001 Feb 15; 21(4):1413-9. PubMed ID: 11160413
    [Abstract] [Full Text] [Related]

  • 7. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
    Haughey HM, Fleckenstein AE, Metzger RR, Hanson GR.
    J Neurochem; 2000 Oct 15; 75(4):1608-17. PubMed ID: 10987842
    [Abstract] [Full Text] [Related]

  • 8. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW, Morford LL, Vorhees CV.
    Synapse; 2005 May 15; 56(2):84-93. PubMed ID: 15714503
    [Abstract] [Full Text] [Related]

  • 9. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL, Sorg BA, Schenk JO.
    Synapse; 2008 Oct 15; 62(10):736-45. PubMed ID: 18651643
    [Abstract] [Full Text] [Related]

  • 10. Rapid and reversible effects of methamphetamine on dopamine transporters.
    Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1997 Aug 15; 282(2):834-8. PubMed ID: 9262348
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
    Kimmel HL, Joyce AR, Carroll FI, Kuhar MJ.
    J Pharmacol Exp Ther; 2001 Jul 15; 298(1):129-40. PubMed ID: 11408534
    [Abstract] [Full Text] [Related]

  • 12. Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.
    Mohd-Yusof A, Veliz A, Rudberg KN, Stone MJ, Gonzalez AE, McDougall SA.
    Psychopharmacology (Berl); 2016 Mar 15; 233(5):893-903. PubMed ID: 26650612
    [Abstract] [Full Text] [Related]

  • 13. Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.
    Alburges ME, Hoonakker AJ, Cordova NM, Robson CM, McFadden LM, Martin AL, Hanson GR.
    Psychopharmacology (Berl); 2014 Aug 15; 231(15):2933-40. PubMed ID: 24522333
    [Abstract] [Full Text] [Related]

  • 14. Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms.
    Cervinski MA, Foster JD, Vaughan RA.
    J Biol Chem; 2005 Dec 09; 280(49):40442-9. PubMed ID: 16204245
    [Abstract] [Full Text] [Related]

  • 15. Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity.
    Kim S, Westphalen R, Callahan B, Hatzidimitriou G, Yuan J, Ricaurte GA.
    J Pharmacol Exp Ther; 2000 May 09; 293(2):625-33. PubMed ID: 10773037
    [Abstract] [Full Text] [Related]

  • 16. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
    Gross NB, Duncker PC, Marshall JF.
    Synapse; 2011 Nov 09; 65(11):1144-55. PubMed ID: 21584865
    [Abstract] [Full Text] [Related]

  • 17. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.
    Zackheim JA, Abercrombie ED.
    Brain Res Bull; 2001 Apr 09; 54(6):603-7. PubMed ID: 11403986
    [Abstract] [Full Text] [Related]

  • 18. Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes.
    Yorgason JT, Hedges DM, Obray JD, Jang EY, Bills KB, Woodbury M, Williams B, Parsons MJ, Andres MA, Steffensen SC.
    Psychopharmacology (Berl); 2020 May 09; 237(5):1317-1330. PubMed ID: 31965252
    [Abstract] [Full Text] [Related]

  • 19. Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
    Westlind-Danielsson A, Gustafsson K, Andersson I.
    Eur J Pharmacol; 1994 Dec 15; 288(1):89-95. PubMed ID: 7705472
    [Abstract] [Full Text] [Related]

  • 20. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.
    Mark KA, Soghomonian JJ, Yamamoto BK.
    J Neurosci; 2004 Dec 15; 24(50):11449-56. PubMed ID: 15601951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.